Last Updated: 31-07-2025 | Format: PDF | Report ID:20111
| Metrics | Details |
|---|---|
| Years | 2020-2035 |
| Base Year | 2025 |
| Market Size | 25200 |
| Regions | England, Scotland, Wales, Northern Ireland |
| Segments | By Type: Branded Drugs, Generic Drugs, Over-the-Counter Drugs, Specialty Drugs, Biosimilars, Orphan Drugs; By Application: Cardiovascular, Oncology, Neurology, Infectious Diseases, Gastrointestinal, Others |
| Players | AstraZeneca, GlaxoSmithKline, Sanofi, Pfizer, Novartis, Johnson & Johnson, Roche, Merck & Co., Eli Lilly, AbbVie, Bayer, Bristol Myers Squibb, Amgen, Boehringer Ingelheim, Teva Pharmaceutical |